echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > New drug combination effective for patients with advanced ovarian cancer

    New drug combination effective for patients with advanced ovarian cancer

    • Last Update: 2022-03-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    "With the limited number of effective combinations currently available to treat patients, new treatments for recurrent ovarian cancer are urgently needed


    Ovarian cancer is the most lethal malignancy in gynecology


    In this phase II study, researchers randomly assigned 78 patients to receive IXA plus BEV or IXA alone


    "We hope our findings will be of great significance in the field of gynecologic oncology, as they add a new, effective treatment to these extremely challenging tumors that otherwise would not have been available


    Dana M.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.